NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced it …
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-photo-12285817.webp?resize=760%2C427&ssl=1)
![](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2023/11/pexels-photo-12285817.webp?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced it …